Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world study
Abstract Avatrombopag (AVA), an oral thrombopoietin receptor agonist (TPO-RA), has demonstrated favorable efficacy in the treatment of pediatric immune thrombocytopenia (ITP). However, treatment-related thrombocytosis represents a clinically relevant adverse event that may compromise treatment safet...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer
2026-06-01
|
| סדרה: | Annals of Hematology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/s00277-026-07086-x |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
